Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Gastroenterology. 2023 Apr;164(4):579-592.e8. doi: 10.1053/j.gastro.2022.12.017. Epub 2022 Dec 29.
BACKGROUND & AIMS: Constitutional mismatch repair deficiency (CMMRD) is a rare recessive childhood cancer predisposition syndrome caused by germline mismatch repair variants. Constitutional microsatellite instability (cMSI) is a CMMRD diagnostic hallmark and may associate with cancer risk. We quantified cMSI in a large CMMRD patient cohort to explore genotype-phenotype correlations using novel MSI markers selected for instability in blood.
Three CMMRD, 1 Lynch syndrome, and 2 control blood samples were genome sequenced to >120× depth. A pilot cohort of 8 CMMRD and 38 control blood samples and a blinded cohort of 56 CMMRD, 8 suspected CMMRD, 40 Lynch syndrome, and 43 control blood samples were amplicon sequenced to 5000× depth. Sample cMSI score was calculated using a published method comparing microsatellite reference allele frequencies with 80 controls.
Thirty-two mononucleotide repeats were selected from blood genome and pilot amplicon sequencing data. cMSI scoring using these MSI markers achieved 100% sensitivity (95% CI, 93.6%-100.0%) and specificity (95% CI 97.9%-100.0%), was reproducible, and was superior to an established tumor MSI marker panel. Lower cMSI scores were found in patients with CMMRD with MSH6 deficiency and patients with at least 1 mismatch repair missense variant, and patients with biallelic truncating/copy number variants had higher scores. cMSI score did not correlate with age at first tumor.
We present an inexpensive and scalable cMSI assay that enhances CMMRD detection relative to existing methods. cMSI score is associated with mismatch repair genotype but not phenotype, suggesting it is not a useful predictor of cancer risk.
胚系错配修复缺陷(CMMRD)是一种罕见的隐性儿童期癌症易感性综合征,由种系错配修复变异引起。 体细胞微卫星不稳定性(cMSI)是 CMMRD 的诊断标志,可能与癌症风险相关。 我们对大量 CMMRD 患者队列进行了 cMSI 定量检测,使用新型 MSI 标志物(这些标志物在血液中不稳定)探索基因型-表型相关性。
对 3 例 CMMRD、1 例林奇综合征和 2 例对照血液样本进行了>120×深度的基因组测序。对 8 例 CMMRD 和 38 例对照血液样本的先导队列和 56 例 CMMRD、8 例疑似 CMMRD、40 例林奇综合征和 43 例对照血液样本的盲法队列进行了 5000×深度的扩增子测序。使用一种已发表的方法,通过比较微卫星参考等位基因频率与 80 个对照样本,计算样本 cMSI 评分。
从血液基因组和先导扩增子测序数据中选择了 32 个单核苷酸重复序列。使用这些 MSI 标志物进行 cMSI 评分,实现了 100%的敏感性(95%CI,93.6%-100.0%)和特异性(95%CI 97.9%-100.0%),可重复性好,优于已建立的肿瘤 MSI 标志物检测。MSH6 缺陷的 CMMRD 患者和至少存在 1 个错配修复错义变异的患者的 cMSI 评分较低,而双等位基因截断/拷贝数变异的患者评分较高。cMSI 评分与首次肿瘤发生的年龄无关。
我们提出了一种廉价且可扩展的 cMSI 检测方法,与现有方法相比,提高了 CMMRD 的检测率。cMSI 评分与错配修复基因型相关,但与表型无关,提示其不是癌症风险的有用预测指标。